1. Home
  2. VCIG vs HOTH Comparison

VCIG vs HOTH Comparison

Compare VCIG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • HOTH
  • Stock Information
  • Founded
  • VCIG 2013
  • HOTH 2017
  • Country
  • VCIG Malaysia
  • HOTH United States
  • Employees
  • VCIG N/A
  • HOTH N/A
  • Industry
  • VCIG Diversified Commercial Services
  • HOTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • HOTH Health Care
  • Exchange
  • VCIG Nasdaq
  • HOTH Nasdaq
  • Market Cap
  • VCIG 7.6M
  • HOTH 8.3M
  • IPO Year
  • VCIG 2023
  • HOTH 2019
  • Fundamental
  • Price
  • VCIG $4.73
  • HOTH $0.86
  • Analyst Decision
  • VCIG
  • HOTH Strong Buy
  • Analyst Count
  • VCIG 0
  • HOTH 3
  • Target Price
  • VCIG N/A
  • HOTH $4.00
  • AVG Volume (30 Days)
  • VCIG 272.2K
  • HOTH 626.3K
  • Earning Date
  • VCIG 05-06-2025
  • HOTH 05-13-2025
  • Dividend Yield
  • VCIG N/A
  • HOTH N/A
  • EPS Growth
  • VCIG N/A
  • HOTH N/A
  • EPS
  • VCIG 156.38
  • HOTH N/A
  • Revenue
  • VCIG $23,548,256.00
  • HOTH N/A
  • Revenue This Year
  • VCIG N/A
  • HOTH N/A
  • Revenue Next Year
  • VCIG N/A
  • HOTH N/A
  • P/E Ratio
  • VCIG $0.03
  • HOTH N/A
  • Revenue Growth
  • VCIG 89.38
  • HOTH N/A
  • 52 Week Low
  • VCIG $2.30
  • HOTH $0.58
  • 52 Week High
  • VCIG $1,372.00
  • HOTH $3.80
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 39.32
  • HOTH 46.70
  • Support Level
  • VCIG $2.30
  • HOTH $0.74
  • Resistance Level
  • VCIG $3.28
  • HOTH $0.84
  • Average True Range (ATR)
  • VCIG 0.73
  • HOTH 0.08
  • MACD
  • VCIG 0.52
  • HOTH 0.01
  • Stochastic Oscillator
  • VCIG 68.63
  • HOTH 83.14

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Share on Social Networks: